等待开盘 09-20 09:30:00 美东时间
+0.015
+6.04%
Mangoceuticals, Inc. (MGRX) has shared an announcement. On August 22, 2024, a c...
08-24 04:59
Mangoceuticals (NASDAQ:MGRX) on Thursday announced that it received a notice of acceptance from the Australian patent authority. The notice of acceptance covers the proprietary formulation and applica...
06-06 21:47
Mangoceuticals, Inc. (MGRX) has issued an update. Mangoceuticals, Inc. has enga...
06-06 06:04
Mangoceuticals (NASDAQ:MGRX) stock jumped 17% in post-market trading Tuesday after the company said it had received a patent notice of allowance in Japan for a proprietary formulation and application ...
06-05 04:52
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones ...
05-22 02:46
Gainers: MGO Global (MGOL) +313%. Mangoceuticals (MGRX) +154%. Borealis Foods (BRLS) +91%. Biodexa Pharmaceuticals (BDRX) +92%. Meta Materials (MMAT) +40%. Intelligent Group Ltd (INTJ) +33%. Complete ...
05-22 01:13
U.S. stocks traded mostly higher midway through trading, with the Dow Jones ind...
05-22 00:00
Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("Trim") to aid in weight management and said it plans to have the products available for customers in the beginning of the 3rd quarter with ‘Slim' and ‘Trim' priced at $299/month and $399/month, respectively.
05-21 22:56
Mangoceuticals press release (NASDAQ:MGRX): Q1 Revenue of $0.21M (+110.0% Y/Y). More on Mangoceuticals Mangoceuticals acquires a global patent portfolio Mangoceuticals signs deal for initial developme...
05-17 04:52